A detailed history of Advent Capital Management transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Advent Capital Management holds 5,000 shares of SRPT stock, worth $607,500. This represents 0.4% of its overall portfolio holdings.

Number of Shares
5,000
Previous 10,000 50.0%
Holding current value
$607,500
Previous $1.58 Million 60.51%
% of portfolio
0.4%
Previous 1.69%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$113.33 - $163.85 $1.13 Million - $1.64 Million
-10,000 Reduced 50.0%
10,000 $1.58 Million
Q1 2024

May 14, 2024

BUY
$93.7 - $141.53 $562,200 - $849,180
6,000 Added 42.86%
20,000 $2.59 Million
Q4 2023

Feb 13, 2024

BUY
$67.31 - $124.76 $942,340 - $1.75 Million
14,000 New
14,000 $1.35 Million
Q1 2023

May 12, 2023

BUY
$117.53 - $155.99 $65,816 - $87,354
560 New
560 $77,000
Q2 2019

Aug 14, 2019

SELL
$112.21 - $151.95 $224,420 - $303,900
-2,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$106.67 - $151.68 $213,340 - $303,360
2,000 New
2,000 $238,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.6B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Advent Capital Management Portfolio

Follow Advent Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advent Capital Management , based on Form 13F filings with the SEC.

News

Stay updated on Advent Capital Management with notifications on news.